Abstract Details
|
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| Jeffrey A. Kaye, MD, FAAN (Oregon Hlth Sci Univ.) | Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care. |
| Hiroko H. Dodge, PhD (Massachusetts General Hospital) | No disclosure on file |
| Deniz Erten-Lyons, MD, FAAN (FDA) | Dr. Erten-Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia Pharamceuticals. |
| William Rooney, PhD (Oregon Health & Science University) | Dr. Rooney has nothing to disclose. |
| Lisa Silbert, MD, FAAN (OHSU) | The institution of Dr. Silbert has received research support from the NIH. Dr. Silbert has received personal compensation in the range of $0-$499 for serving as a Peer Reviewer, study section with NIH. |
| Zbigniew K. Wszolek, MD, FAAN (Mayo Clinic- Jacksonville) | Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care. |